The U.S. Treasury Department and IRS, jointly with the Labor Department and Department of Health and Human Services, this afternoon released for publication in the Federal Register an interim final rule (T.D. 9931) with respect to Medicare coverage concerning a vaccine for the disease caused by the coronavirus (COVID-19).
The interim final rule [PDF 530 KB] (64 pages as published in the Federal Register on November 6, 2020) describes implementation of a provision of the “Coronavirus Aid, Relief, and Economic Security Act” (CARES Act) that established Medicare Part B coverage and payment for a COVID-19 vaccine and its administration. The preamble to the interim final rule states that it is intended that “every American has timely access to a COVID-19 vaccine without any out-of-pocket expenses, no matter their source of coverage, or whether they are covered at all.”
Today’s release implements other provisions of the CARES Act—such as that the prices of COVID-19 diagnostic tests are to be made public—and establishes an add-on payment for cases involving the use of new COVID-19 treatments and provides for separate payment for new COVID-19 treatments.
This interim final rule also amends regulations regarding coverage of preventive health services to implement a provision of the CARES Act that shortens the timeframe within which non-grandfathered group health plans and health insurance issuers offering non-grandfathered group or individual health insurance coverage must begin to cover without cost sharing qualifying coronavirus preventive services, including recommended COVID-19 immunizations.
The purpose of this report is to provide text of the interim final rule.
The KPMG logo and name are trademarks of KPMG International. KPMG International is a Swiss cooperative that serves as a coordinating entity for a network of independent member firms. KPMG International provides no audit or other client services. Such services are provided solely by member firms in their respective geographic areas. KPMG International and its member firms are legally distinct and separate entities. They are not and nothing contained herein shall be construed to place these entities in the relationship of parents, subsidiaries, agents, partners, or joint venturers. No member firm has any authority (actual, apparent, implied or otherwise) to obligate or bind KPMG International or any member firm in any manner whatsoever. The information contained in herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavor to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act on such information without appropriate professional advice after a thorough examination of the particular situation. For more information, contact KPMG's Federal Tax Legislative and Regulatory Services Group at: + 1 202 533 4366, 1801 K Street NW, Washington, DC 20006.